Las Vegas, NV -- (SBWIRE) -- 01/06/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Rockwell Medical Inc(NASDAQ:RMTI), Veeva Systems Inc(NYSE:VEEV), BioCryst Pharmaceuticals, Inc.(NASDAQ:BCRX), Gafisa SA (ADR)(NYSE:GFA)
Rockwell Medical Inc(NASDAQ:RMTI) was a volume gainer of 1.61 million shares and the average volume of the stock remained 1.18 million shares. The stock opened the session at $10.43 and finished at the end of the day at $9.88 and the stock plunged -5.27% .The market capitalizations of the stock remained 395.18 million. Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. The company offers products and services for the treatment of end-stage renal disease, chronic kidney disease (CKD), iron deficiency, secondary hyperparathyroidism, and hemodialysis (HD).
Has RMTI Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, Veeva Systems Inc(NYSE:VEEV) exchanged 1.61 million shares and the average volume remained 964,676.00 shares. The stock closed the session at $35.17 with the gain of 8.78%. Veeva Systems Inc. provides industry-specific cloud-based software solutions for the life sciences industry in North America, Europe, and the Asia Pacific. The company?s solutions enable pharmaceutical and other life sciences companies to realize the benefits of cloud-based architectures and mobile applications for their critical business functions. Veeva Systems Inc. was founded in 2007 and is headquartered in Pleasanton, California.
Will VEEV Continue To Move Higher? Find Out Here
BioCryst Pharmaceuticals, Inc.(NASDAQ:BCRX) enhanced 7.09% and its closing price was $8.46. The volume of the stock was 1.58 million shares and the average volume remained 947,543.00 shares. The market capitalization of the stock remained 499.91 million. The beta of the stock remained 3.03. BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops novel drugs that block key enzymes involved in the pathogenesis of diseases. Biocryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
Why Should Investors Buy BCRX After The Recent Gain? Just Go Here and Find Out
Gafisa SA (ADR)(NYSE:GFA) exchanged 1.58 million shares in the previous trading session, and its average trading remained 1.55 million shares. GFA advanced 6.23% and it closed the trading at $3.07. The market capitalization of the stock remained 666.96 million. Gafisa S.A. operates as a homebuilder in Brazil. The company operates in three segments: Gafisa, Tenda, and Alphaville. It engages in the development of residential buildings, including luxury buildings with swimming pools, gyms, visitor parking, Gafisa S.A. was incorporated in 1996 and is headquartered in Sao Paulo, Brazil.
For How Long GFA’s Gloss will Attract Investors? Find out via this report
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)